Healthy Extracts (HYEX) Other financing activities (2015 - 2025)

Healthy Extracts' (HYEX) quarterly Other financing activities came in at -$64838.0 in Q4 2025, down 259.53% quarter-over-quarter from $40643.0 in Q3 2025.

Healthy Extracts (HYEX) Other financing activities (2015 - 2025) Analysis & Trends

Healthy Extracts' Other financing activities history runs 5 years deep, the most recent figure standing at -$64838.0 for Q4 2025.

  • On a quarterly basis, Other financing activities changed N/A year-over-year to -$64838.0 in Q4 2025; TTM through Dec 2025 was -$24195.0, a N/A change from a year earlier, with the FY2025 full-year figure at -$58364.0, changed N/A from the prior year.
  • Other financing activities eased to -$64838.0 in Q4 2025 per HYEX's latest filing, from $40643.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $40643.0 in Q3 2025 and bottomed at -$64838.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Healthy Extracts 14.70 Mn 14.56 Mn 957,429.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -64,838.00
Dec 31, 2025 -64,838.00
Sep 30, 2025 40,643.00
Sep 30, 2025 40,643.00
Mar 31, 2022 -16,890.00
Mar 31, 2022 -16,890.00
Mar 31, 2018 -1,500.00
Mar 31, 2018 -1,500.00
Jun 30, 2016 32,500.00
Jun 30, 2016 32,500.00
Mar 31, 2016 5,000.00
Mar 31, 2016 5,000.00
Dec 31, 2015 25,000.00
Dec 31, 2015 25,000.00